Device Trial Radar · NCT04896645
Albuterol Integrated Adherence Monitoring in Children With Asthma
Last checked: Nov 19, 2026Latest source record: Nov 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
21
Actual
Start
Jun 1, 2021
Primary completion
Jun 22, 2022
Study completion Jun 22, 2022
Sponsor
- Lead sponsor
- Children's Hospital Los AngelesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Teva Pharmaceuticals USA
- First posted
- May 21, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Supportive care
- FDA-regulated device
- No
- Who can join
- All sexes, from 8 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The investigators propose to evaluate whether an integrated electronic adherence monitoring albuterol rescue inhaler can improve proper use in a mostly minority and inner-city population of children treated for asthma at the Children's Hospital of Los Angeles
Conditions
- Asthma in Children
Interventions
Digihaler Albuterol Device by TEVADevice
Patient with asthma will have their regular albuterol rescue inhaler replaced with Digihaler, they will also be asked to perform gamified spirometry (Aluna) at home
Primary outcomes
What the sponsor says the trial is designed to measure.
- Asthma OutcomesTime frame: 3 months
- Asthma AdherenceTime frame: 3 months
- Asthma AdherenceTime frame: 3 months
3 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Children's Hospital Los Angeles
Los Angeles, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.